Torrent Pharmaceuticals Ltd — Gliclazide Exporter Profile
Indian Pharmaceutical Exporter · #6 for Gliclazide · $6.1M export value · DGFT Verified
Torrent Pharmaceuticals Ltd is the #6 Indian exporter of Gliclazide with $6.1M in export value and 217 verified shipments. Torrent Pharmaceuticals Ltd holds a 3.2% market share in Gliclazide exports across 3 countries.
Torrent Pharmaceuticals Ltd — Gliclazide Export Profile: Buyers & Destinations
Where Does Torrent Pharmaceuticals Ltd Export Gliclazide?
Torrent Pharmaceuticals Ltd exports Gliclazide to 3 countries. The largest destination is BRAZIL accounting for 93.6% of Torrent Pharmaceuticals Ltd's Gliclazide shipments, followed by SRI LANKA (6.3%) and CAMBODIA (0.1%). These destinations reflect Torrent Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Gliclazide from Torrent Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TORRENT DO BRASIL LTDA | BRAZIL | $5.6M | 226 |
| TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.3M | 58 |
| HATTON NATIONAL BANK PLC | SRI LANKA | $183.4K | 4 |
| HSBC. | SRI LANKA | $50.3K | 2 |
| COMMERCIAL BANK OF CEYLON PLC | SRI LANKA | $50.0K | 1 |
| HATTON NATIONAL BANK PLC. | SRI LANKA | $50.0K | 1 |
| HSBC | SRI LANKA | $32.2K | 1 |
| HATTON NATIONAL BANK | SRI LANKA | $32.2K | 3 |
| TO THE ORDER OF | CAMBODIA | $31.0K | 2 |
| THE ORDER OF HATTON NATIONAL BANK P | SRI LANKA | $26.4K | 1 |
Torrent Pharmaceuticals Ltd supplies Gliclazide to 11 buyers globally. The largest buyer is TORRENT DO BRASIL LTDA (BRAZIL), followed by TORRENT DO BRASIL LIMITEDA (BRAZIL) and HATTON NATIONAL BANK PLC (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Gliclazide Export Value and How Much Does Torrent Pharmaceuticals Ltd Contribute?
India exported $68.5M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. Torrent Pharmaceuticals Ltd contributes $6.1M to this total, accounting for 3.2% of India's Gliclazide exports. Torrent Pharmaceuticals Ltd ships Gliclazide to 3 countries through 11 buyers.
What Is the Average Shipment Value for Torrent Pharmaceuticals Ltd's Gliclazide Exports?
Torrent Pharmaceuticals Ltd's average Gliclazide shipment value is $28.1K per consignment, based on 217 shipments totaling $6.1M. The largest destination is BRAZIL (93.6% of Torrent Pharmaceuticals Ltd's Gliclazide exports).
How Does Torrent Pharmaceuticals Ltd Compare to Other Indian Gliclazide Exporters?
Torrent Pharmaceuticals Ltd ranks #6 among 238 Indian Gliclazide exporters with a 3.2% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($15.1M), MICRO LABS LIMITED ($7.6M), IPCA LABORATORIES LIMITED ($7.3M). Torrent Pharmaceuticals Ltd processed 217 shipments to 3 destination countries.
What Gliclazide Formulations Does Torrent Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZUKON MR TABLET ( GLICLAZIDE MODIFIED R | $1.0M | 29 |
| AZUKON MR TABLET (GLICLAZIDE MODIFIED RE | $305.3K | 10 |
| AZUKON MR TABLET GLICLAZIDE 30MG MODIFIED RELEASE TABLETS NOS SIZE 10X10 TABLETS | $300.0K | 6 |
| AZUKON MR TABLET ( GLICLAZIDE MODIFIED RELEASE 30MG ) NOS SIZE 3X10 TABLETS | $260.3K | 6 |
| GLICLAZIDE MR 30MG TABLETS ( GLICLAZIDE | $241.6K | 12 |
| AZUKON MR TABLET GLICLAZIDE MODIFIED R | $240.8K | 7 |
| GLICLAZIDE MR 30MG TABLETS GLICLAZIDEMODIFIED RELEASE 30 MG NOS SIZE 3 X 10TABLETS | $212.4K | 11 |
| GLICLAZIDE MR 30mg TABLETS ( GLICLAZIDE | $189.5K | 9 |
| GLICLAZIDE MR 30MG TABLETS (GLICLAZIDE M | $165.7K | 11 |
| AZUKON MR TABLET ( GLICLAZIDE MODIFIED RELEASE TABLETS 30 MG ) NOS SIZE 6X10 TABLETS | $160.5K | 8 |
Torrent Pharmaceuticals Ltd exports 98 distinct Gliclazide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZUKON MR TABLET ( GLICLAZIDE MODIFIED R with 29 shipments worth $1.0M.
Regulatory Requirements: Exporting Gliclazide to Key Markets
What Torrent Pharmaceuticals Ltd must comply with to export Gliclazide to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Torrent Pharmaceuticals Ltd Compare to Nearest Gliclazide Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | IPCA LABORATORIES LIMITED | $7.3M | 243 | 18 | $30.2K |
| 1 | MYLAN LABORATORIES LIMITED | $6.7M | 133 | 7 | $50.0K |
| 6 | TORRENT PHARMACEUTICALS LTD ★ | $6.1M | 217 | 3 | $28.1K |
| 7 | LUPIN LIMITED | $4.9M | 145 | 8 | $33.6K |
| 8 | MEDREICH LIMITED | $3.6M | 82 | 2 | $43.3K |
Torrent Pharmaceuticals Ltd ranks #6 among 238 Indian Gliclazide exporters. Average shipment value of $28.1K compared to the market average of $287.6K. The closest competitors by value are IPCA LABORATORIES LIMITED and MYLAN LABORATORIES LIMITED.
Which Indian Ports Ship Gliclazide Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 439 | 11.5% |
| SAHAR AIR | 375 | 9.8% |
| JNPT/ NHAVA SHEVA SEA | 323 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 247 | 6.4% |
| DELHI AIR | 229 | 6.0% |
| JNPT | 203 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 165 | 4.3% |
| CMA CGM LOGISTICS PARK ICD | 103 | 2.7% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Gliclazide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Torrent Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 300 individual customs records matching Torrent Pharmaceuticals Ltd exporting Gliclazide, covering 98 formulations to 3 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Gliclazide Export Data from Torrent Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Torrent Pharmaceuticals Ltd's Gliclazide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Torrent Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Gliclazide Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Torrent Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current shipment-level data, contact TransData Nexus.